Table of Contents
1 Table of Contents 3
1.1 List of Tables 7
1.2 List of Figures 8
2
Introduction 9
2.1 What Is This Report About? 9
2.2 Definitions 9
2.2.1 Orthopedic Devices 9
2.2.1.1 Orthobiologics 9
3 Company Snapshot
10
3.1 Key Information 10
3.2 Company Overview 10
3.3 Financial
Performance 10
3.4 Industry Outlook -- Orthopedic Devices 10
4
Business Description 11
4.1 Business Overview 11
4.2 Major Products
and Services 12
4.2.1 Overview 12
5 History 13
6 Competitors
15
7 Osteotech, Inc. Medical Equipment Market Share Analysis 16
7.1
Osteotech, Inc. Global, Market share (2007) 16
7.2 Osteotech, Inc. North
America, Market share (2007) 16
8 Key Employees 17
9 Key Employee
Biographies 18
10 Company Statement 19
11 Locations And Subsidiaries
20
11.1 Head Office 20
12 Financial Deals Landscape 21
12.1
Acquisition 21
12.1.1 Musculoskeletal Transplant Terminates Its Proposal
To Acquire Osteotech 21
12.2 IPO 22
12.2.1 Osteotech Completes $17.5
Million Private Placement 22
12.3 Partnership 23
12.3.1 Osteotech
Signs Distribution Agreement with Biohorizons 23
12.3.2 Osteotech Signs an
Agreement with Harvest Technologies 24
12.3.3 Osteotech Enters Into
License Agreement with Bacterin International 25
12.3.4 Osteotech Enters
Into License Agreement with Rutgers 27
12.3.5 Osteotech And Smith & Nephew
Enter Into Processing And Distribution Agreement 28
12.3.6 Osteotech and
LifeNet Form Partnership 29
12.3.7 Osteotech Terminates Its Distribution
Agreement with SpineVision 30
13 Recent Developments 32
13.1 Product
Announcements 32
13.1.1 Apr 28, 2008 Osteotech, Inc. Plexur P Receives FDA
Clearance as Bone Void Filler and Bone Graft Extender in Spine 32
13.1.2
Mar 04, 2008 Osteotech Receives FDA Clearance for Plexur M Biocomposite
32
13.1.3 Apr 30, 2008: Osteotech Signs Distribution Agreement With
BioHorizons 33
13.1.4 Apr 18, 2008: Osteotech Renew Tissue Recovery
Agreement with EATA 33
13.2 Financial Announcements 33
13.2.1 May 01,
2008: Osteotech Reports Q1 2008 Results 33
13.2.2 Apr 17, 2008: Osteotech
To Declare Q1 2008 Results 34
13.2.3 Feb 20, 2008: Osteotech Reports Q4
2007 Results 34
13.2.4 Feb 15, 2008: Osteotech To Declare Q4 2007 Results
35
13.2.5 Nov 06, 2007: Osteotech Reports Q3 2007 Results 35
13.2.6
Aug 01, 2007: Osteotech Declares Q2 2007 Results 35
13.2.7 May 09, 2007:
Osteotech Declares Q1 2007 Results 36
13.2.8 Mar 08, 2007: Osteotech
Declares Q4 2006 Results 37
13.3 Other Significant Developments 38
13.3.1 Apr 11, 2007: Osteotech Appoints New Board Member 38
13.3.2 Aug 21,
2006: Osteotech Appoints New Board Member 38
14 Osteotech, Inc. Pipeline
Products 39
14.1 Osteo-biologic Material 39
14.1.1 Product Overview
39
14.1.2 Product Description 39
14.1.3 Product Status 39
14.2
Spinal Tension Band 39
14.2.1 Product Overview 39
14.2.2 Product
Description 39
14.2.3 Product Status 40
14.3 DuraTech 40
14.3.1
Product Overview 40
14.3.2 Product Description 40
14.3.3 Product
Status 40
14.4 Plexur M Biocomposite 40
14.4.1 Product Overview 40
14.4.2 Product Description 40
14.4.3 Product Status 41
14.4.4 Product
Milestone 41
14.5 Next Generation DBM 42
14.5.1 Product Overview
42
14.5.2 Product Description 42
14.5.3 Product Status 42
14.5.4
Product Patent Details 42
15 Appendix 44
15.1 Global Markets Direct
Research Methodology 44
15.2 Coverage 45
15.3 Secondary Research
45
15.4 Primary Research 46
15.5 Models 46
15.6 Forecasts 47
15.7 Expert Panels 47
15.8 Market Revenue Chapters 47
15.8.1
Abbreviations 47
15.8.2 Currency Conversions 48
15.9 Contact Us 49
15.10 Disclaimer 49
1.1 List of Tables
Table 1: Osteotech,
Inc. Key Facts 10
Table 2: Osteotech, Inc. Orthopedic Devices by
category, Global, Revenue ($ mn) and Market Share (%), 2007 16
Table 3:
Osteotech, Inc. Orthopedic Devices by category, North America, Revenue ($ mn)
and Market Share (%), 2007 16
Table 4: Osteotech, Inc. Orthopedic Devices
by category, United States, Revenue ($ mn) and Market Share (%), 2007 16
Table 5: Osteotech, Inc. Key Employees, 17
Table 6: Abbreviations
used in the Market Revenue Chapters 47
Table 7: Currency Conversion used
in the Market Revenue Chapters 48
1.2 List of Figures
Figure 1:
Global Markets Direct Methodology 44
View Cart
